-
1
-
-
77951879058
-
Aldosterone: Effects on the kidney and cardiovascular system
-
Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol. 2010;6:261-273.
-
(2010)
Nat Rev Nephrol
, vol.6
, pp. 261-273
-
-
Briet, M.1
Schiffrin, E.L.2
-
2
-
-
81855183776
-
Mineralocorticoid receptor antagonists for heart failure
-
Richards AM. Mineralocorticoid receptor antagonists for heart failure. Expert Opin Pharmacother. 2011;12:2801-2815.
-
(2011)
Expert Opin Pharmacother
, vol.12
, pp. 2801-2815
-
-
Richards, A.M.1
-
3
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
-
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes, J.8
-
4
-
-
0037417252
-
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
-
Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
-
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321.
-
(2003)
N Engl J Med
, vol.348
, pp. 1309-1321
-
-
Pitt, B.1
Remme, W.2
Zannad, F.3
Neaton, J.4
Martinez, F.5
Roniker, B.6
Bittman, R.7
Hurley, S.8
Kleiman, J.9
Gatlin, M.10
-
5
-
-
78650399880
-
Eplerenone in patients with systolic heart failure and mild symptoms
-
EMPHASIS-HF Study Group
-
Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11-21.
-
(2011)
N Engl J Med
, vol.364
, pp. 11-21
-
-
Zannad, F.1
McMurray, J.J.2
Krum, H.3
Van Veldhuisen, D.J.4
Swedberg, K.5
Shi, H.6
Vincent, J.7
Pocock, S.J.8
Pitt, B.9
-
7
-
-
77954056940
-
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: Current status
-
Ma TK, Kam KK, Yan BP, Lam YY. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol. 2010;160:1273-1292.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1273-1292
-
-
Ma, T.K.1
Kam, K.K.2
Yan, B.P.3
Lam, Y.Y.4
-
8
-
-
0000432665
-
Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor
-
Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med. 2001;7:605-611.
-
(2001)
Nat Med
, vol.7
, pp. 605-611
-
-
Hsu, S.Y.1
Hsueh, A.J.2
-
9
-
-
7444272894
-
CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators
-
Wiley KE, Davenport AP. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol. 2004;143:508-514.
-
(2004)
Br J Pharmacol
, vol.143
, pp. 508-514
-
-
Wiley, K.E.1
Davenport, A.P.2
-
10
-
-
78650405397
-
CAMP- and Ca2(+)/calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes
-
Yang LZ, Kockskämper J, Khan S, Suarez J, Walther S, Doleschal B, Unterer G, Khafaga M, Mächler H, Heinzel FR, Dillmann WH, Pieske B, Spiess J. cAMP- and Ca2(+)/calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes. Br J Pharmacol. 2011;162:544-556.
-
(2011)
Br J Pharmacol
, vol.162
, pp. 544-556
-
-
Yang, L.Z.1
Kockskämper, J.2
Khan, S.3
Suarez, J.4
Walther, S.5
Doleschal, B.6
Unterer, G.7
Khafaga, M.8
Mächler, H.9
Heinzel, F.R.10
Dillmann, W.H.11
Pieske, B.12
Spiess, J.13
-
11
-
-
12144290844
-
The cardiovascular physiologic actions of urocortin II: Acute effects in murine heart failure
-
Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW, Peterson KL. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc Natl Acad Sci USA. 2004;101:3697-3702.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 3697-3702
-
-
Bale, T.L.1
Hoshijima, M.2
Gu, Y.3
Dalton, N.4
Anderson, K.R.5
Lee, K.F.6
Rivier, J.7
Chien, K.R.8
Vale, W.W.9
Peterson, K.L.10
-
12
-
-
33644877288
-
Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: Beneficial effects in heart failure
-
Rademaker MT, Cameron VA, Charles CJ, Richards AM. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation. 2005;112:3624-3632.
-
(2005)
Circulation
, vol.112
, pp. 3624-3632
-
-
Rademaker, M.T.1
Cameron, V.A.2
Charles, C.J.3
Richards, A.M.4
-
13
-
-
42549101298
-
Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure
-
Rademaker MT, Charles CJ, Nicholls MG, Richards AM. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. Clin Sci (Lond). 2008;114:635-642.
-
(2008)
Clin Sci (Lond)
, vol.114
, pp. 635-642
-
-
Rademaker, M.T.1
Charles, C.J.2
Nicholls, M.G.3
Richards, A.M.4
-
14
-
-
77952521665
-
Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure
-
Rademaker MT, Charles CJ, Nicholls MG, Richards AM. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure. Circ Heart Fail. 2009;2:532-540.
-
(2009)
Circ Heart Fail
, vol.2
, pp. 532-540
-
-
Rademaker, M.T.1
Charles, C.J.2
Nicholls, M.G.3
Richards, A.M.4
-
15
-
-
79956337356
-
Prolonged urocortin 2 administration in experimental heart failure: Sustained hemodynamic, endocrine, and renal effects
-
Rademaker MT, Charles CJ, Ellmers LJ, Lewis LK, Nicholls MG, Richards AM. Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and renal effects. Hypertension. 2011;57:1136-1144.
-
(2011)
Hypertension
, vol.57
, pp. 1136-1144
-
-
Rademaker, M.T.1
Charles, C.J.2
Ellmers, L.J.3
Lewis, L.K.4
Nicholls, M.G.5
Richards, A.M.6
-
16
-
-
35948950184
-
Urocortin 2 infusion in human heart failure
-
Davis ME, Pemberton CJ, Yandle TG, Fisher SF, Lainchbury JG, Frampton CM, Rademaker MT, Richards M. Urocortin 2 infusion in human heart failure. Eur Heart J. 2007;28:2589-2597.
-
(2007)
Eur Heart J
, vol.28
, pp. 2589-2597
-
-
Davis, M.E.1
Pemberton, C.J.2
Yandle, T.G.3
Fisher, S.F.4
Lainchbury, J.G.5
Frampton, C.M.6
Rademaker, M.T.7
Richards, M.8
-
18
-
-
33644799148
-
Effects of intravenous urocortin on angiotensin-converting enzyme in rats
-
Yang C, Xu Y, Mendez T, Wang F, Yang Q, Li S. Effects of intravenous urocortin on angiotensin-converting enzyme in rats. Vascul Pharmacol. 2006;44:238-246.
-
(2006)
Vascul Pharmacol
, vol.44
, pp. 238-246
-
-
Yang, C.1
Xu, Y.2
Mendez, T.3
Wang, F.4
Yang, Q.5
Li, S.6
-
19
-
-
26444456075
-
Endogenous urocortins reduce vascular tone and reninaldosterone/ endothelin activity in experimental heart failure
-
Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Lainchbury JG, Richards AM. Endogenous urocortins reduce vascular tone and reninaldosterone/ endothelin activity in experimental heart failure. Eur Heart J. 2005;26:2046-2054.
-
(2005)
Eur Heart J
, vol.26
, pp. 2046-2054
-
-
Rademaker, M.T.1
Charles, C.J.2
Espiner, E.A.3
Frampton, C.M.4
Lainchbury, J.G.5
Richards, A.M.6
-
20
-
-
0024561778
-
Neurohumoral changes during onset and offset of ovine heart failure: Role of ANP
-
Fitzpatrick MA, Nicholls MG, Espiner EA, Ikram H, Bagshaw P, Yandle TG. Neurohumoral changes during onset and offset of ovine heart failure: role of ANP. Am J Physiol. 1989;256(4 Pt 2):H1052-H1059.
-
(1989)
Am J Physiol
, vol.256
, Issue.4 PART 2
-
-
Fitzpatrick, M.A.1
Nicholls, M.G.2
Espiner, E.A.3
Ikram, H.4
Bagshaw, P.5
Yandle, T.G.6
-
21
-
-
0029985313
-
Natriuretic peptide responses to acute and chronic pacing in sheep
-
Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, Richards AM. Natriuretic peptide responses to acute and chronic pacing in sheep. Am J Physiol. 1996;270:H594-H602.
-
(1996)
Am J Physiol
, vol.270
-
-
Rademaker, M.T.1
Charles, C.J.2
Espiner, E.A.3
Frampton, C.M.4
Nicholls, M.G.5
Richards, A.M.6
-
22
-
-
0025324128
-
Hemodynamic and hormonal effects of renin inhibition in ovine heart failure
-
Fitzpatrick MA, Rademaker MT, Frampton CM, Charles CJ, Yandle TG, Espiner EA, Ikram H. Hemodynamic and hormonal effects of renin inhibition in ovine heart failure. Am J Physiol. 1990;258 (6 Pt 2):H1625-H1631.
-
(1990)
Am J Physiol
, vol.258
, Issue.6 PART 2
-
-
Fitzpatrick, M.A.1
Rademaker, M.T.2
Frampton, C.M.3
Charles, C.J.4
Yandle, T.G.5
Espiner, E.A.6
Ikram, H.7
-
23
-
-
0031975483
-
Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: Role of natriuretic peptides and angiotensin II
-
Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM, Kosoglou T. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II. J Cardiovasc Pharmacol. 1998;31:116-125.
-
(1998)
J Cardiovasc Pharmacol
, vol.31
, pp. 116-125
-
-
Rademaker, M.T.1
Charles, C.J.2
Espiner, E.A.3
Nicholls, M.G.4
Richards, A.M.5
Kosoglou, T.6
-
24
-
-
0030790899
-
Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep
-
Charles CJ, Rademaker MT, Richards AM, Cooper GJ, Coy DH, Jing NY, Nicholls MG. Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. Am J Physiol. 1997;272(6 Pt 2):R2040-R2047.
-
(1997)
Am J Physiol
, vol.272
, Issue.6 PART 2
-
-
Charles, C.J.1
Rademaker, M.T.2
Richards, A.M.3
Cooper, G.J.4
Coy, D.H.5
Jing, N.Y.6
Nicholls, M.G.7
-
25
-
-
4744368848
-
Effects of the aldosterone receptor antagonist potassium canrenoate on renal blood flow and urinary output during prolonged increased intraabdominal pressure (IAP) in pigs
-
Gudmundsson FF, Viste A, Myking OL, Grong K, Svanes K. Effects of the aldosterone receptor antagonist potassium canrenoate on renal blood flow and urinary output during prolonged increased intraabdominal pressure (IAP) in pigs. Surg Endosc. 2004;18:1528-1534.
-
(2004)
Surg Endosc
, vol.18
, pp. 1528-1534
-
-
Gudmundsson, F.F.1
Viste, A.2
Myking, O.L.3
Grong, K.4
Svanes, K.5
-
26
-
-
0022133564
-
Effect of aldosterone on potassium excretion during potassium chloride infusion in sheep
-
Rabinowitz L, Sarason RL, Yamauchi H. Effect of aldosterone on potassium excretion during potassium chloride infusion in sheep. Am J Physiol. 1985;249(4 Pt 2):R455-R461.
-
(1985)
Am J Physiol
, vol.249
, Issue.4 PART 2
-
-
Rabinowitz, L.1
Sarason, R.L.2
Yamauchi, H.3
-
27
-
-
0027427833
-
Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans
-
van Buren M, Boer P, Koomans HA. Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans. J Clin Endocrinol Metab. 1993;77:902-909.
-
(1993)
J Clin Endocrinol Metab
, vol.77
, pp. 902-909
-
-
Van Buren, M.1
Boer, P.2
Koomans, H.A.3
-
28
-
-
0037939688
-
Relaxation by urocortin of rat renal arteries: Effects of diabetes in males and females
-
Sanz E, Fernández N, Monge L, Climent B, Diéguez G, García-Villalón AL. Relaxation by urocortin of rat renal arteries: effects of diabetes in males and females. Cardiovasc Res. 2003;58:706-711.
-
(2003)
Cardiovasc Res
, vol.58
, pp. 706-711
-
-
Sanz, E.1
Fernández, N.2
Monge, L.3
Climent, B.4
Diéguez, G.5
García-Villalón, A.L.6
-
29
-
-
71249092636
-
Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: Disruption of an endogenous inhibitor of angiogenesis and proliferation
-
Tezval H, Jurk S, Atschekzei F, Becker JU, Jahn O, Serth J, Kuczyk MA. Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation. World J Urol. 2009;27:825-830.
-
(2009)
World J Urol
, vol.27
, pp. 825-830
-
-
Tezval, H.1
Jurk, S.2
Atschekzei, F.3
Becker, J.U.4
Jahn, O.5
Serth, J.6
Kuczyk, M.A.7
-
30
-
-
46249094420
-
Urocortin ameliorates diabetic nephropathy in obese db/db mice
-
Li X, Hu J, Zhang R, Sun X, Zhang Q, Guan X, Chen J, Zhu Q, Li S. Urocortin ameliorates diabetic nephropathy in obese db/db mice. Br J Pharmacol. 2008;154:1025-1034.
-
(2008)
Br J Pharmacol
, vol.154
, pp. 1025-1034
-
-
Li, X.1
Hu, J.2
Zhang, R.3
Sun, X.4
Zhang, Q.5
Guan, X.6
Chen, J.7
Zhu, Q.8
Li, S.9
-
31
-
-
70350336006
-
Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF
-
Li X, Hu J, Zhang Q, Sun X, Li S. Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF. Br J Pharmacol. 2009;157:994-1003.
-
(2009)
Br J Pharmacol
, vol.157
, pp. 994-1003
-
-
Li, X.1
Hu, J.2
Zhang, Q.3
Sun, X.4
Li, S.5
-
33
-
-
0023678639
-
Acute effect of potassium canrenoate administration on renin-angiotensin, kallikrein-kinin and prostaglandin systems
-
Lahera V, Cachofeiro V, Duran F, Cañizo FJ, Rodriguez FJ, Tresguerres JA. Acute effect of potassium canrenoate administration on renin-angiotensin, kallikrein-kinin and prostaglandin systems. Gen Pharmacol. 1988;19:835-839.
-
(1988)
Gen Pharmacol
, vol.19
, pp. 835-839
-
-
Lahera, V.1
Cachofeiro, V.2
Duran, F.3
Cañizo, F.J.4
Rodriguez, F.J.5
Tresguerres, J.A.6
-
34
-
-
79952142761
-
Differential effects of mineralocorticoid blockade on the hypothalamo-pituitary-adrenal axis in pregnant and nonpregnant ewes
-
Lingis M, Richards EM, Keller-Wood M. Differential effects of mineralocorticoid blockade on the hypothalamo-pituitary-adrenal axis in pregnant and nonpregnant ewes. Am J Physiol Endocrinol Metab. 2011;300:E592-E599.
-
(2011)
Am J Physiol Endocrinol Metab
, vol.300
-
-
Lingis, M.1
Richards, E.M.2
Keller-Wood, M.3
-
35
-
-
75149173528
-
Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep
-
Charles CJ, Jardine DL, Rademaker MT, Richards AM. Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep. J Endocrinol. 2010;204:181-189.
-
(2010)
J Endocrinol
, vol.204
, pp. 181-189
-
-
Charles, C.J.1
Jardine, D.L.2
Rademaker, M.T.3
Richards, A.M.4
-
36
-
-
58849164929
-
Effect of single treatment with the antihypertensive drug eplerenone on hormone levels and anxiety-like behaviour in rats
-
Hlavacova N, Jezova D. Effect of single treatment with the antihypertensive drug eplerenone on hormone levels and anxiety-like behaviour in rats. Endocr Regul. 2008;42:147-153.
-
(2008)
Endocr Regul
, vol.42
, pp. 147-153
-
-
Hlavacova, N.1
Jezova, D.2
-
37
-
-
79957821827
-
Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland
-
Squillacioti C, De Luca A, Liguori G, Paino S, Mirabella N. Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland. Gen Comp Endocrinol. 2011;172:416-422.
-
(2011)
Gen Comp Endocrinol
, vol.172
, pp. 416-422
-
-
Squillacioti, C.1
De Luca, A.2
Liguori, G.3
Paino, S.4
Mirabella, N.5
-
38
-
-
84855642277
-
Non-genomic actions of aldosterone: From receptors and signals to membrane targets
-
Dooley R, Harvey BJ, Thomas W. Non-genomic actions of aldosterone: from receptors and signals to membrane targets. Mol Cell Endocrinol. 2012;350:223-234.
-
(2012)
Mol Cell Endocrinol
, vol.350
, pp. 223-234
-
-
Dooley, R.1
Harvey, B.J.2
Thomas, W.3
-
39
-
-
0033539910
-
Rapid nongenomic effects of aldosterone in mineralocorticoid- receptor-knockout mice
-
Haseroth K, Gerdes D, Berger S, Feuring M, Günther A, Herbst C, Christ M, Wehling M. Rapid nongenomic effects of aldosterone in mineralocorticoid- receptor-knockout mice. Biochem Biophys Res Commun. 1999;266:257-261.
-
(1999)
Biochem Biophys Res Commun
, vol.266
, pp. 257-261
-
-
Haseroth, K.1
Gerdes, D.2
Berger, S.3
Feuring, M.4
Günther, A.5
Herbst, C.6
Christ, M.7
Wehling, M.8
-
40
-
-
6344288979
-
Elevated resting and exercise- induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans
-
Wellhoener P, Born J, Fehm HL, Dodt C. Elevated resting and exercise- induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans. J Clin Endocrinol Metab. 2004;89:5048-5052.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5048-5052
-
-
Wellhoener, P.1
Born, J.2
Fehm, H.L.3
Dodt, C.4
-
41
-
-
0035076428
-
Physiological roles of corticotropin-releasing hormone receptor type 2
-
Hashimoto K, Makino S, Asaba K, Nishiyama M. Physiological roles of corticotropin-releasing hormone receptor type 2. Endocr J. 2001;48:1-9.
-
(2001)
Endocr J
, vol.48
, pp. 1-9
-
-
Hashimoto, K.1
Makino, S.2
Asaba, K.3
Nishiyama, M.4
-
42
-
-
0033847611
-
Effect of spironolactone and its metabolites on contractile property of isolated rat aorta rings
-
Sorrentino R, Autore G, Cirino G, d'Emmanuele de Villa Bianca R, Calignano A, Vanasia M, Alfieri C, Sorrentino L, Pinto A. Effect of spironolactone and its metabolites on contractile property of isolated rat aorta rings. J Cardiovasc Pharmacol. 2000;36:230-235.
-
(2000)
J Cardiovasc Pharmacol
, vol.36
, pp. 230-235
-
-
Sorrentino, R.1
Autore, G.2
Cirino, G.3
D'Emmanuele De Villa Bianca, R.4
Calignano, A.5
Vanasia, M.6
Alfieri, C.7
Sorrentino, L.8
Pinto, A.9
-
43
-
-
77954434421
-
The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure
-
Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, Labat C, Benjamin L, Farman N, Lacolley P, Henrion D, Jaisser F. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J. 2010;24:2454-2463.
-
(2010)
FASEB J
, vol.24
, pp. 2454-2463
-
-
Nguyen Dinh Cat, A.1
Griol-Charhbili, V.2
Loufrani, L.3
Labat, C.4
Benjamin, L.5
Farman, N.6
Lacolley, P.7
Henrion, D.8
Jaisser, F.9
-
44
-
-
33646695467
-
Urocortin II improves calcium handling and contractility in isolated cardiac myocytes from wild-type and muscle LIM protein knock-out mice
-
Dieterle T, Belke DD, Hoshijima M, Chien KR, Bale T, Vale WW, Dillmann WH, Perterson KL. Urocortin II improves calcium handling and contractility in isolated cardiac myocytes from wild-type and muscle LIM protein knock-out mice. Circulation. 2003;108(suppl IV):341.
-
(2003)
Circulation
, vol.108
, Issue.SUPPL. IV
, pp. 341
-
-
Dieterle, T.1
Belke, D.D.2
Hoshijima, M.3
Chien, K.R.4
Bale, T.5
Vale, W.W.6
Dillmann, W.H.7
Perterson, K.L.8
-
45
-
-
14644388102
-
Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats
-
Abdelrahman AM, Lin Lim S, Pang CC. Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats. Eur J Pharmacol. 2005;510:107-111.
-
(2005)
Eur J Pharmacol
, vol.510
, pp. 107-111
-
-
Abdelrahman, A.M.1
Lin Lim, S.2
Pang, C.C.3
|